Navigation Links
Adeona Receives Excellence in Science & Technology Award
Date:3/8/2011

ANN ARBOR, Mich., March 8, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN), a developer of innovative medicines for serious central nervous system diseases, announced today that it received a Corp! Magazine 2011 Digital, Science & Technology Award.  As an honoree, the Company is highlighted in the magazine's Special Edition e-Publication. The Corp! Magazine article featuring Adeona is available via the "Adeona in the News" section on the home page of the Company's website at www.adeonapharma.com.

About Adeona Pharmaceuticals, Inc.

Adeona is a pharmaceutical company developing innovative medicines for the treatment of serious central nervous system diseases. The Company's strategy is to license product candidates that have demonstrated a certain level of clinical efficacy and develop them to a stage that results in a significant commercial collaboration. Currently, Adeona is developing the following product candidates: a prescription medical food for Alzheimer's disease, and drugs for multiple sclerosis, fibromyalgia, age-related macular degeneration and rheumatoid arthritis. For more information, please visit Adeona's website at www.adeonapharma.com.


'/>"/>
SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Adeona Appoints George J. Brewer, M.D., Senior Vice President of Research & Development
2. Adeona Mourns the Passing of David A. Newsome, M.D., Senior Vice President of Research & Development
3. Adeonas Alzheimers Disease Pivotal Clinical Study Results Abstract Accepted for Presentation at the American Academy of Neurologys 63rd Annual Meeting
4. Adeona to Raise $4 Million in Registered Direct Offering
5. Adeona to Host Investor Day on Zinc Deficiency in Alzheimers Disease
6. Adeona to Present at OneMedForum San Francisco 2011 Conference
7. Adeona Acquires Access to Clinical Data Supporting Oral Zinc for Prevention of Infections in the Elderly
8. Adeona Announces Third Quarter 2010 Financial Results and Achievements
9. Adeona to Hold Annual Shareholder Meeting
10. Adeona CEO to Provide Keynote Address at the 2010 MichBio Expo & Conference Emerging Biosciences Showcase
11. Adeona Announces Five Scientific Publications on Role of Copper Toxicity and Zinc Deficiency in Alzheimers Disease and Cognitive Decline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Sept. 22, 2014 Children,s National ... Monday, Sept. 29 at 5 p.m. EDT for ... competition, in response to continued strong interest from ... each will be awarded to the winning presentations ... Innovation Symposium hosted by Children,s National in October. ...
(Date:9/22/2014)... , Sept. 22, 2014  Elusys Therapeutics, ... to treat infectious disease, today announced it has ... studies of obiltoxaximab (ETI-204). Obiltoxaximab is an anti-toxin ... and data from these studies support the safety ... (IV) at the intended therapeutic dose. The conclusion ...
(Date:9/22/2014)... and SHANGHAI , Sept. 22, ... a global knowledge leader in healthcare technology, media ... support healthcare innovation in China ... health technologies. Continua and BHG announced this new ... held this week in Washington, DC ...
Breaking Medicine Technology:Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 2Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 4Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 5Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 6Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4
... 2012  Pharmaceutical marketers who need to calibrate multi-channel marketing ... limitless questions. SyntheSight™ , a new ... with a patent-pending IntelliScore™ , provides ... leaders find answers. SyntheSight ...
... the fastest growing Electronic Medical Record ... its award winning e-prescribing software has been revamped; ... experience based on community feedback. The company,s free ... interactions for medical professionals in 2011 alone. ...
Cached Medicine Technology:RMi Introduces SyntheSight™ Pharma Multi-Channel Optimization Suite 2RMi Introduces SyntheSight™ Pharma Multi-Channel Optimization Suite 3Practice Fusion's Top-Rated e-Prescribing Software Gets a Doctor-Driven Makeover 2Practice Fusion's Top-Rated e-Prescribing Software Gets a Doctor-Driven Makeover 3
(Date:9/23/2014)... UK and The Gambia, have developed a new approach ... direct sequencing of DNA extracted from sputum (a technique ... cause TB without the need for time-consuming culture of ... today in the peer-reviewed journal PeerJ ... Microbial Genomics at Warwick Medical School and Dr Martin ...
(Date:9/23/2014)... Wohl Associates of Bohemia, ... has recently taken delivery of used industrial pasta machinery ... sheeters, and equipment for producing gnocchi and tortelloni. , ... and a La Parmigiana mixer/extruder. With a 2.2 kW ... tank that is 17” wide, 28” long and 23” ...
(Date:9/23/2014)... A 2014 study supported by the ... has found that rising temperatures and hotter ... children developing kidney stones. Researchers based their findings ... U.S. cities, including Dallas, Atlanta, Philadelphia, Chicago and Los ... for kidney stones within a relatively short span – ...
(Date:9/23/2014)... NV (PRWEB) September 23, 2014 September ... Experts at Emassagechair.com want to help people improve their ... to take steps either big or small to make ... is to help people evaluate their lives and make ... the home, starting an exercise program, or getting on ...
(Date:9/23/2014)... 23, 2014 Computer Resources of America, ... in New York City, has been awarded the contract ... clients located in the NY Metro geography for a ... the bank’s corporate and trading floor midtown and Jersey ... and their NY Metro disaster recovery locations. The ...
Breaking Medicine News(10 mins):Health News:Researchers develop new DNA sequencing method to diagnose tuberculosis 2Health News:Used Industrial Pasta Machinery Now Available at Wohl Associates 2Health News:New Study Finds Link Between Higher Temperatures and Kidney Stones in the United States 2Health News:New Study Finds Link Between Higher Temperatures and Kidney Stones in the United States 3Health News:Emassagechair.com is Celebrating Self-Improvement Month by Giving Away a Foot Massager 2Health News:Emassagechair.com is Celebrating Self-Improvement Month by Giving Away a Foot Massager 3
... ... association with the American Sleep Apnea Association (ASAA). , ... (Vocus) July 15, 2009 -- Snoring Isn,t Sexy, LLC is honored ... American Sleep Apnea Association is the only non-profit organization dedicated to educating the public about ...
... ... (MHS), the leading provider of clinical supply chain solutions, announced today ... is the only flexible, three-step solution that reduces the cost of ... draws on extensive experience working with leading health systems and detailed ...
... , , , ... drug might work were among the advances in potential therapies targeting two ... reported today at the Alzheimer,s Association 2009 International Conference on Alzheimer,s Disease ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090529/ICADLOGO ) , ...
... ... nutritionist, and anti-aging specialist, is now a featured expert on searchjointpain.com, a new informational ... , ... July 14, 2009 -- Dr. Stephen Sinatra , a board-certified cardiologist, nutritionist, and ...
... , , WASHINGTON, July 14 Speaker ... Miller, Chairman John Dingell and other senior House Democrats held a press conference in ... the Tri-Committees on health care reform. , , ... , Speaker Pelosi. Good afternoon. ...
... , , WASHINGTON, July 14 ... Charles Rangel, Chairman George Miller, Chairman John Dingell and other senior House ... legislation introduced today by the Tri-Committees on health care reform. ... opening remarks and closing statement. A transcript of the entire press conference ...
Cached Medicine News:Health News:Snoring Isn't Sexy, LLC Announces Professional Relationship with the American Sleep Apnea Association 2Health News:Management Health Solutions, Inc. Announces Optimal Inventory Control™ (OptIC™) Solution 2Health News:Management Health Solutions, Inc. Announces Optimal Inventory Control™ (OptIC™) Solution 3Health News:A Phase III Alzheimer's Drug Increases Levels of Beta Amyloid in the Brain - But Still Provides Benefits 2Health News:A Phase III Alzheimer's Drug Increases Levels of Beta Amyloid in the Brain - But Still Provides Benefits 3Health News:A Phase III Alzheimer's Drug Increases Levels of Beta Amyloid in the Brain - But Still Provides Benefits 4Health News:A Phase III Alzheimer's Drug Increases Levels of Beta Amyloid in the Brain - But Still Provides Benefits 5Health News:A Phase III Alzheimer's Drug Increases Levels of Beta Amyloid in the Brain - But Still Provides Benefits 6Health News:A Phase III Alzheimer's Drug Increases Levels of Beta Amyloid in the Brain - But Still Provides Benefits 7Health News:Board-Certified Cardiologist Dr. Stephen Sinatra Featured on Searchjointpain.com 2Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 2Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 3Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 4Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 5Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 6Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 7Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 8Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 9Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 10Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 11Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 12Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 13Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 14Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 15Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 16Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 17Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 18Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 19Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 20Health News:Pelosi Remarks at Press Conference on Introduction of Health Care Legislation 2Health News:Pelosi Remarks at Press Conference on Introduction of Health Care Legislation 3
... Units,Filter units with hydrophobic PTFE membranes,Millex ... are ideal for the sterilizing filtration ... containers, and for sterilizing or clarifying ... Millex filter units are available with ...
The incorporation of a reverse osmosis (RO) system and an ultrapure water system into a single stand-alone tower provides numerous benefits to the busy laboratory....
... Basic Laboratory Needs, Synergy systems produce ultrapure water ... 1 to 1.2 L/min to meet the basic ... incorporates a dual-wavelength UV lamp (185 nm and ... of organic contaminants (< 5 ppb TOC when ...
... mechanism for speed, stability and durability. ... display modes, multiple units of measure, ... auto print, and GLP/GMP/ISO output including ... clock. Built-in, motor-driven internal calibration ...
Medicine Products: